The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

Artículo original

Año: 2019

Guanabens, N; Moro-Alvarez, MJ; Casado, E; Blanch-Rubio, J; Gomez-Alonso, C; Diaz-Guerra, GM; del Pino-Montes, J; de Lamadrid, CVD; Peris, P; Munoz-Torres, M

Título: ENDOCRINE

• Q2